Protein predicts sickle-cell danger
From Atlanta, at a meeting of the American Society of Hematology
A biological marker of heart trouble can be used to identify sickle-cell anemia patients who are at greatest risk of developing a serious complication.
Pulmonary hypertension—high blood pressure of the arteries in the lungs—puts stress on the heart and is a major cause of disability and death among sickle-cell patients. Doctors can diagnose pulmonary hypertension using an echocardiogram, but they have difficulty predicting which patients will develop it.
Science News headlines, in your inbox
Headlines and summaries of the latest Science News articles, delivered to your email inbox every Thursday.
Thank you for signing up!
There was a problem signing you up.
To try a different approach, Roberto Machado of the National Heart, Lung, and Blood Institute in Bethesda, Md., and his colleagues tested blood samples from 275 volunteers for B-type natriuretic peptide (BNP). In patients with other disorders, the heart is known to overproduce that protein when it has difficulty pumping.
In sickle-cell patients with pulmonary hypertension, the average BNP concentration was 206 picograms per milliliter (pg/ml). By contrast, average BNP was just 29 pg/ml in healthy volunteers and 46 pg/ml in sickle-cell patients who hadn’t developed the blood-pressure disorder, Machado’s team found.
To test BNP’s value as a prognostic tool, Machado’s team then measured the protein in blood samples taken in 1996 from 121 other sickle-cell patients. The researchers found that patients who had at least 160 pg/ml BNP in 1996 were three times as likely to have died by 2005 as patients with lower BNP levels were.